Anti-Yersinia V-antigen Recombinant Antibody (17A5.1) (MRO-147MZ) (CAT#: MRO-147MZ)

This antibody (clone 17A5.1) against Yersinia V-antigen is capable of inhibiting a Yersinia infection. It recognizes the whole V-antigen (V0), but not the V1 or V2 region.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
WB

Figure 1 Immunoblots prepared with absorbed rabbit polyclonal anti-native V antigen (A), mouse monoclonal anti-V antigen 15A4.8 (B), and mouse monoclonal anti-V antigen 17A5.1 (C) against extracts of E. coli BL21(DE3)/pBluescript SK⁺ (lanes 1), E. coli BL21(DE3)/ pBVP515D (lanes 2), E. coli BL21(DE3)/pBVP514D (lanes 3), E. coli BL21(DE3)/pBVP53D (lanes 4), E. coli BL21(DE3)/pBVP513D (lanes 5), E. coli BL21(DE3)/pBVP5 (lanes 6), Lcr⁺ Y pestis KIM (lanes 7), and Lcr-Y pestis KIM (lanes 8). Numbers on the right indicate molecular masses in kilodaltons.

Figure 1 Immunoblots prepared with absorbed rabbit polyclonal anti-native V antigen (A), mouse monoclonal anti-V antigen 15A4.8 (B), and mouse monoclonal anti-V antigen 17A5.1 (C) against extracts of E. coli BL21(DE3)/pBluescript SK⁺ (lanes 1), E. coli BL21(DE3)/ pBVP515D (lanes 2), E. coli BL21(DE3)/pBVP514D (lanes 3), E. coli BL21(DE3)/pBVP53D (lanes 4), E. coli BL21(DE3)/pBVP513D (lanes 5), E. coli BL21(DE3)/pBVP5 (lanes 6), Lcr⁺ Y pestis KIM (lanes 7), and Lcr-Y pestis KIM (lanes 8). Numbers on the right indicate molecular masses in kilodaltons.

Passive immunity to Yersiniae mediated by anti-recombinant V-antigen and Protein A-V antigen fusion peptide

WB

Figure 2 Immunoblots prepared with polyclonal anti-native V antigen (A) or mouse monoclonal anti-V antigen 17A5.1 (B) directed against truncated protein A (LANES 1),PAV (LANES 2),PAV partially hydrolyzed by formic acid and then passed through the IgG-Sepharose 6FF column (lane 4), whole Ca²⁺-starved Lcr⁺ cells of Y.pestis KIM (LANE 6).

Figure 2 Immunoblots prepared with polyclonal anti-native V antigen (A) or mouse monoclonal anti-V antigen 17A5.1 (B) directed against truncated protein A (LANES 1),PAV (LANES 2),PAV partially hydrolyzed by formic acid and then passed through the IgG-Sepharose 6FF column (lane 4), whole Ca²⁺-starved Lcr⁺ cells of Y.pestis KIM (LANE 6).

Passive immunity to Yersiniae mediated by anti-recombinant V-antigen and Protein A-V antigen fusion peptide


Specifications

  • Host Species
  • Mouse
  • Specificity
  • Yersinia
  • Clone
  • 17A5.1
  • Applications
  • WB
  • Related Disease
  • Yersinia infection

Applications

  • Application Notes
  • The LCRV antibody has been reported in applications of Western Blot.

Target

  • Alternative Names
  • Yersinia V-antigen

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 17A5.1"

See other products for "lcrV"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-147MZ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare